Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.
Pathology of Multiple Sclerosis.
B-cell-directed therapy: which B cells should be targeted and how?
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
Curcuminoids in Neurodegenerative Diseases.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
CNS diseases and uveitis.
Feedforward postural control in individuals with multiple sclerosis during load release.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
Neuroscience. Myelin--more than insulation.
Uses of complementary and alternative medicine in multiple sclerosis.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Effects of vitamin d3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
B cell exchange across the blood-brain barrier in multiple sclerosis.
Early development of anti-natalizumab antibodies in MS patients.
Information regarding Active Biotech's candidate drug laquinimod
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.

Pages